2661 - 2670 of 6255 Results
Title
Year
-
OPENTitle: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00604-yBest OA location URL: https://www.nature.com/articles/s41531-023-00604-y.pdfCitation Count: 30
-
OPENTitle: Studying the Parkinson’s disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot studyJournal Name: Analytical and Bioanalytical ChemistryPublisher: Springer Science and Business Media LLCVol: 414Issue #: 25Start Page: 7399End Page: 7419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00216-022-04207-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00216-022-04207-z.pdfCitation Count: 27
-
OPENTitle: Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiencyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-38484-0Best OA location URL: https://www.nature.com/articles/s41598-023-38484-0.pdfCitation Count: 5
-
OPENTitle: The Interaction betweenHLA‐DRB1and Smoking in Parkinson's Disease RevisitedJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1929End Page: 1937Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29133Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01348%22Citation Count: 8
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Citation Count: 43
-
OPENTitle: Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 7Start Page: 482End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.317Best OA location URL: https://escholarship.org/content/qt1349p44j/qt1349p44j.pdfCitation Count: 27
-
OPENTitle: Impact ofGBA1variants on long-term clinical progression and mortality in incident Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 7Start Page: 695End Page: 702Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2020-322857Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/7/695.full.pdfCitation Count: 76
-
OPENTitle: Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuICJournal Name: FEBS Open BioPublisher: WileyVol: 10Issue #: 5Start Page: 883End Page: 893Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/2211-5463.12844Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.12844Citation Count: 9
-
OPENTitle: Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesiaJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 6Start Page: 2246End Page: 2255Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10411-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11197155Citation Count: 12
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4201593Citation Count: 69